3D MRE-Based Evaluation of Meningioma Mechanical Properties and Histological Features
Recruiting now · Not applicable
Conditions studied: Meningioma
In brief
This prospective single-center study aims to evaluate the feasibility and clinical utility of three-dimensional magnetic resonance elastography (3D MRE) in assessing tumor stiffness and adhesion in patients with meningioma undergoing surgical resection. By correlating preoperative MRE-derived stiffness and adhesion maps with intraoperative findings and histopathological features, the study seeks to determine whether MRE can serve as a noninvasive imaging biomarker for surgical planning, risk stratification, and prediction of tumor behavior.
Key facts
- Study ID
- NCT06955208
- Run by
- Shengjing Hospital
- People needed
- 300
- Starts
- 2022-10-19
- Expected to finish
- 2027-10-09
- Last updated by the study team
- 2026-02-12
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- All patients undergoing meningeoma resection surgery are eligible for inclusion in the study cohort.
You may not qualify if…
- Patients with metallic implants or foreign bodies in their bodies (pacemakers, artificial metallic heart valves, metal joints, metal implants, and those who can not remove dentures, insulin pumps, or contraceptive rings)
- Pregnant women in the first trimester (within three months)
- Patients with severe claustrophobia or anxiety
- Patients with severe fever
- Patients who can not tolerate MRE
- Patients with vascular malformations and aneurysms.
- Patients who do not sign an informed consent
Where it is running
- Shengjing Hospital — Shenyang, Liaoning, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.